On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. The "new" Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer.The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013.
According to Miles White, CEO at the time, the purpose of the split was to allow markets to value the two businesses separately; White said that investors would "benefit from two fundamentally different investment opportunities with distinct strategic profiles and business priorities."Some investors were concerned that the split was done to protect the value of the device business from the loss of value facing the drug division due to the imminent expiration of patents on Humira, which accounted for about half of the drug division's revenue.
As of December 2015, the company employed in excess of 28,000 globally, and provided products to individuals in more than 170 countries
Canopy Growth is a pure growth play: Canopy Growth Corporation, is based in Smiths Falls, Ontario. Tweed was founded by Bruce Linton and Chuck Rifici in 2013, and renamed Canopy Growth Corporation in 2015. Some reliable sources also list Mark Zekulin as a co-founder; he became the sole CEO as of early July 2019 after Linton was ousted from the company.
By April 2019, Canopy was the world's largest cannabis company, based on the value of all shares, or market capitalization.At that time, Constellation Brands Inc. controlled over 35% percent of the company which had approximately 3,200 employees.
0 Comments